Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07823400) titled 'MIECC vs Conventional Cardiopulmonary Bypass and Systemic Inflammation in CABG' on Sept. 10.

Study Type: Observational

Primary Sponsor: Bursa Yuksek Ihtisas Training and Research Hospital

Condition: Coronary Artery Disease Systemic Inflammation

Intervention: Procedure: Minimally Invasive Extracorporeal Circulation

Recruitment Status: Recruiting

Date of First Enrollment: February 7, 2026

Target Sample Size: 80

Countries of Recruitment: Turkey (Turkiye)

To know more, visit https://clinicaltrials.gov/study/NCT07823400

Published by HT Digital Content Services with permission from Health Daily Digest....